Literature DB >> 20537586

What do symptom scores mean: observations on discrepancies when defining symptoms using words and numbers.

Ashlinder Gill1, Patricia Daines, Debbie Selby.   

Abstract

UNLABELLED: The Edmonton Symptom Assessment System (ESAS) has become a more frequently used tool for symptom screening in oncology and palliative care settings in Ontario. The process patients use to select symptom scores however is poorly understood.
PURPOSE: The purpose of this paper is to consider what patients mean when assigning numbers or words to symptoms, and the implications for healthcare providers who interpret these responses. METHODS AND SAMPLE: A previously conducted study in our organization asked four hundred inpatient and ambulatory oncology patients to rank ESAS symptoms with the usual numerical responses (0-10) and then with word phrases of 'none', 'mild', 'moderate', or 'severe' to examine the relationship between chosen numbers and words. KEY
RESULTS: Although results showed a strong positive correlation between number and word rankings for each ESAS symptom, closer examination revealed that for some patients there were discrepancies between chosen numbers and words, with broad numerical ranges, particularly for the words 'mild' and 'moderate'. Through a secondary analysis, these discrepant responses are explored and relevant literature is presented that highlights the importance of understanding patients as they communicate their symptoms.
CONCLUSIONS: Health care providers need to be aware of the potential for discrepancies when reviewing patient self-reported data. Numbers and words may not fully capture a patient's symptom burden; further exploration is required to gain a more comprehensive understanding of a patient's current state of being.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20537586     DOI: 10.1016/j.ejon.2010.04.002

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  3 in total

1.  Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions.

Authors:  J J Koldenhof; P O Witteveen; R de Vos; M Walraven; C N Tillier; H M W Verheul; S C C M Teunissen
Journal:  Support Care Cancer       Date:  2014-04-02       Impact factor: 3.603

2.  Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.

Authors:  Jung Hye Kwon; Seung-Hyun Nam; Sujin Koh; Young Seon Hong; Kyung Hee Lee; Sang-Won Shin; David Hui; Kyun Woo Park; So Young Yoon; Ji Yun Won; Gary Chisholm; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2013-04-28       Impact factor: 3.612

3.  The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.

Authors:  Benjamin D Diplock; Kaitlin M C McGarragle; Willem A Mueller; Sana Haddad; Rachel Ehrlich; Dong-Hyun A Yoon; Xingshan Cao; Yaseen Al-Allaq; Paul Karanicolas; Margaret I Fitch; Jeff Myers; Alex J Mitchell; Janet W M Ellis
Journal:  Support Care Cancer       Date:  2018-06-21       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.